Clioquinol

DRUG3 trials

Sponsors

UZ Leuven, University Health Network, Toronto, KU Leuven

Conditions

Acute Lymphocytic LeukemiaAcute Myeloid LeukemiaChronic Lymphocytic LeukemiaDrug resistant epilepsyEpilepsy IntractableHodgkin's LymphomaLymphoma, Non-HodgkinMultiple Myeloma

Phase 1

Study Evaluating the Tolerance and Biological Activity of Oral Clioquinol in Patients With Relapsed or Refractory Hematological Malignancy

TerminatedNCT00963495

University Health Network, TorontoAcute Lymphocytic Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia +4

Start: 2009-08-31End: 2013-09-30Updated: 2015-06-22

Phase 2

Add-on Clioquinol in Drug-resistant Childhood Epilepsy: an Exploratory Study

KU LeuvenEpilepsy Intractable

Start: 2022-03-01End: 2023-12-31Target: 10Updated: 2023-02-14

Add-on Clioquinol in drug-resistant epilepsy: an exploratory study

RecruitingCTIS2024-511388-27-04

UZ LeuvenDrug resistant epilepsy

Start: 2024-07-16Target: 20Updated: 2025-10-29